We are live on ! Find out more
WEC

Winslow Evans & Crocker Portfolio holdings

AUM $528M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+24.39%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
AUM
$375M
AUM Growth
+$70.9M
Cap. Flow
+$6.82M
Cap. Flow %
1.82%
Top 10 Hldgs %
27.07%
Holding
1,203
New
83
Increased
198
Reduced
494
Closed
49

Sector Composition

Rank Sector Weight
1 Technology 27.09%
2 Healthcare 15.02%
3 Financials 10.96%
4 Consumer Discretionary 9.84%
5 Communication Services 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AME icon
751
Ametek
AME
$55.4B
$9K ﹤0.01%
100
BMRN icon
752
BioMarin Pharmaceuticals
BMRN
$11.6B
$9K ﹤0.01%
77
-1
-1% -$99
BOTZ icon
753
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.28B
$9K ﹤0.01%
365
+213
+140% +$4.57K
DGRW icon
754
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.7B
$9K ﹤0.01%
200
DON icon
755
WisdomTree US MidCap Dividend Fund
DON
$4.03B
$9K ﹤0.01%
300
EMB icon
756
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$9K ﹤0.01%
85
-1
-1% -$103
FGD icon
757
First Trust Dow Jones Global Select Dividend Index Fund
FGD
$1.54B
$9K ﹤0.01%
500
FXR icon
758
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$728M
$9K ﹤0.01%
250
IART icon
759
Integra LifeSciences
IART
$1.29B
$9K ﹤0.01%
190
ING icon
760
ING
ING
$99.8B
$9K ﹤0.01%
1,253
-1
-0.1% -$6
IONS icon
761
Ionis Pharmaceuticals
IONS
$8.6B
$9K ﹤0.01%
150
JFR icon
762
Nuveen Floating Rate Income Fund
JFR
$1.24B
$9K ﹤0.01%
1,200
OMC icon
763
Omnicom Group
OMC
$21.6B
$9K ﹤0.01%
170
ORA icon
764
Ormat Technologies
ORA
$6B
$9K ﹤0.01%
135
-1
-0.7% -$65
PEY icon
765
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.13B
$9K ﹤0.01%
600
RARE icon
766
Ultragenyx Pharmaceutical
RARE
$2.45B
$9K ﹤0.01%
112
RVP icon
767
Retractable Technologies
RVP
$19.8M
$9K ﹤0.01%
+1,335
New +$6.18K
RWX icon
768
State Street SPDR Dow Jones International Real Estate ETF
RWX
$269M
$9K ﹤0.01%
296
SAM icon
769
Boston Beer
SAM
$1.91B
$9K ﹤0.01%
+17
New +$8.23K
SLAB icon
770
Silicon Laboratories
SLAB
$7.17B
$9K ﹤0.01%
90
SYLD icon
771
Cambria Shareholder Yield ETF
SYLD
$987M
$9K ﹤0.01%
290
WNEB icon
772
Western New England Bancorp
WNEB
$259M
$9K ﹤0.01%
1,500
ZBRA icon
773
Zebra Technologies
ZBRA
$14B
$9K ﹤0.01%
35
-1
-3% -$234
DLPH
774
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$9K ﹤0.01%
650
ADPT icon
775
Adaptive Biotechnologies
ADPT
$3.59B
$8K ﹤0.01%
165
-1
-0.6% -$36

Similar funds

Winslow Evans & Crocker's Q2 2020 Portfolio in Review

As of Q2 2020, Winslow Evans & Crocker held 1,203 positions worth $375M, up 23% from $304M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Winslow Evans & Crocker's Q2 2020 filing shows 83 new, 198 increased, 494 reduced and 49 closed positions. Its largest new stake was Vertex Pharmaceuticals: 2,423 shares worth $703K. The largest sale was HDFC Bank, an estimated $692K.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Winslow Evans & Crocker's largest Q2 2020 buy was Vertex Pharmaceuticals: 2,423 shares worth $703K.
  • Winslow Evans & Crocker added most to RingCentral in Q2 2020, an estimated $764K increase.
  • Winslow Evans & Crocker's biggest Q2 2020 reduction was HDFC Bank, cutting an estimated $692K.
  • Winslow Evans & Crocker fully exited Kansas City Southern in Q2 2020, selling an estimated $388K.
  • Winslow Evans & Crocker's ten largest holdings make up 27% of its $375M portfolio in Q2 2020.
  • Winslow Evans & Crocker opened 83 new positions and closed 49 in Q2 2020.
  • Winslow Evans & Crocker's portfolio value rose 23% quarter-over-quarter to $375M.

Based on Winslow Evans & Crocker's 13F filing for Q2 2020, filed 23 Jul 2020.